Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-07-21 Sale | 2021-07-23 4:54 pm | ALEXION PHARMACEUTICALS INC. | ALXN | COUGHLIN CHRISTOPHER J Director | 42,347 | $0 | $0 | 0 (Direct) | View |
| 2021-07-21 Sale | 2021-07-23 4:52 pm | ALEXION PHARMACEUTICALS INC. | ALXN | SARIN ARADHANA EVP, CFO | 120,253 | $0 | $0 | 0 (Direct) | View |
| 2021-07-21 Sale | 2021-07-23 4:51 pm | ALEXION PHARMACEUTICALS INC. | ALXN | FRIEDMAN PAUL A Director | 12,840 | $0 | $0 | 0 (Direct) | View |
| 2021-07-21 Sale | 2021-07-23 4:49 pm | ALEXION PHARMACEUTICALS INC. | ALXN | Reinsdorf Judith A Director | 14,150 | $0 | $0 | 0 (Direct) | View |
| 2021-07-21 Sale | 2021-07-23 4:48 pm | ALEXION PHARMACEUTICALS INC. | ALXN | Dunsire Deborah Director | 14,629 | $0 | $0 | 0 (Direct) | View |
| 2021-07-21 Sale | 2021-07-23 4:47 pm | ALEXION PHARMACEUTICALS INC. | ALXN | Carino Tanisha EVP & CCAO | 59,226 | $0 | $0 | 0 (Direct) | View |
| 2021-07-21 Sale | 2021-07-23 4:45 pm | ALEXION PHARMACEUTICALS INC. | ALXN | Mollen John T Director | 15,336 | $0 | $0 | 0 (Direct) | View |
| 2021-07-21 Sale | 2021-07-23 4:44 pm | ALEXION PHARMACEUTICALS INC. | ALXN | Brennan David R Director | 20,873 | $0 | $0 | 0 (Direct) | View |
| 2021-07-21 Sale | 2021-07-23 4:42 pm | ALEXION PHARMACEUTICALS INC. | ALXN | Goff Brian EVP & Chief Commercial Officer | 150,832 | $0 | $0 | 0 (Direct) | View |
| 2021-07-21 Sale | 2021-07-23 4:40 pm | ALEXION PHARMACEUTICALS INC. | ALXN | Chiniara Ellen EVP & Chief Legal Officer | 116,850 | $0 | $0 | 0 (Direct) | View |
| 2021-07-21 Sale | 2021-07-23 4:39 pm | ALEXION PHARMACEUTICALS INC. | ALXN | Bazarko Daniel SVP, Controller, CAO | 60,207 | $0 | $0 | 0 (Direct) | View |
| 2021-07-21 Sale | 2021-07-23 4:37 pm | ALEXION PHARMACEUTICALS INC. | ALXN | Franchini Indrani Lall EVP, Chief Compliance Officer | 116,075 | $0 | $0 | 0 (Direct) | View |
| 2021-07-21 Sale | 2021-07-23 4:36 pm | ALEXION PHARMACEUTICALS INC. | ALXN | Nader Francois Director | 13,921 | $0 | $0 | 0 (Direct) | View |
| 2021-07-21 Sale | 2021-07-23 4:34 pm | ALEXION PHARMACEUTICALS INC. | ALXN | Rummelt Andreas Director | 28,109 | $0 | $0 | 0 (Direct) | View |
| 2021-07-21 Sale | 2021-07-23 4:32 pm | ALEXION PHARMACEUTICALS INC. | ALXN | HANTSON LUDWIG CEO | 580,809 | $0 | $0 | 9,098 (Direct) | View |
| 2021-07-21 Sale | 2021-07-23 4:29 pm | ALEXION PHARMACEUTICALS INC. | ALXN | ORLOFF JOHN J EVP, Research & Development | 146,511 | $0 | $0 | 0 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-07-14 Option Award | 2021-07-16 4:56 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | HANTSON LUDWIG CEO | 240,741 | $0 | 589,907 (Direct) | View |
| 2021-07-14 Option Award | 2021-07-16 4:54 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | SARIN ARADHANA EVP, CFO | 56,313 | $0 | 120,253 (Direct) | View |
| 2021-07-14 Option Award | 2021-07-16 4:53 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | Franchini Indrani Lall EVP, Chief Compliance Officer | 52,625 | $0 | 116,075 (Direct) | View |
| 2021-07-14 Option Award | 2021-07-16 4:49 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | Bazarko Daniel SVP, Controller, CAO | 21,708 | $0 | 60,207 (Direct) | View |
| 2021-07-14 Option Award | 2021-07-16 4:48 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | ORLOFF JOHN J EVP, Research & Development | 60,144 | $0 | 146,511 (Direct) | View |
| 2021-07-14 Option Award | 2021-07-16 4:46 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | Chiniara Ellen EVP & Chief Legal Officer | 54,469 | $0 | 116,850 (Direct) | View |
| 2021-07-14 Option Award | 2021-07-16 4:45 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | Carino Tanisha EVP & CCAO | 25,813 | $0 | 59,226 (Direct) | View |
| 2021-07-14 Option Award | 2021-07-16 4:43 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | Goff Brian EVP & Chief Commercial Officer | 60,144 | $0 | 150,832 (Direct) | View |
| 2021-06-08 Tax Withholding | 2021-06-09 4:53 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | ORLOFF JOHN J EVP, Research & Development | 1,957 | $177 | 86,367 (Direct) | View |
| 2021-06-08 Tax Withholding | 2021-06-09 4:52 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | Goff Brian EVP & Chief Commercial Officer | 1,086 | $177 | 90,688 (Direct) | View |
| 2021-06-08 Tax Withholding | 2021-06-09 4:50 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | Franchini Indrani Lall EVP, Chief Compliance Officer | 928 | $177 | 63,450 (Direct) | View |
| 2021-05-20 Option Award | 2021-05-24 4:36 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | COUGHLIN CHRISTOPHER J Director | 2,691 | $0 | 42,347 (Direct) | View |
| 2021-05-20 Option Award | 2021-05-24 4:34 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | FRIEDMAN PAUL A Director | 2,495 | $0 | 12,840 (Direct) | View |
| 2021-05-20 Option Award | 2021-05-24 4:33 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | Rummelt Andreas Director | 2,495 | $0 | 28,109 (Direct) | View |
| 2021-05-20 Option Award | 2021-05-24 4:32 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | Reinsdorf Judith A Director | 2,635 | $0 | 14,150 (Direct) | View |
| 2021-05-20 Option Award | 2021-05-24 4:30 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | Nader Francois Director | 2,635 | $0 | 13,921 (Direct) | View |
| 2021-05-20 Option Award | 2021-05-24 4:29 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | Mollen John T Director | 2,635 | $0 | 15,336 (Direct) | View |
| 2021-05-20 Option Award | 2021-05-24 4:27 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | Dunsire Deborah Director | 2,495 | $0 | 14,629 (Direct) | View |
| 2021-05-20 Option Award | 2021-05-24 4:25 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | Brennan David R Director | 3,336 | $0 | 20,873 (Direct) | View |
| 2021-03-29 Tax Withholding | 2021-04-01 07:44 am | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | HANTSON LUDWIG CEO | 2,332 | $154.03 | 349,166 (Direct) | View |
| 2021-02-28 Option Award | 2021-03-02 6:01 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | HANTSON LUDWIG CEO | 83,725 | $0 | 351,498 (Direct) | View |
| 2021-03-01 Tax Withholding | 2021-03-02 5:59 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | Carino Tanisha EVP & CCAO | 722 | $151.75 | 33,413 (Direct) | View |
| 2021-02-28 Option Award | 2021-03-02 5:59 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | Carino Tanisha EVP & CCAO | 18,033 | $0 | 33,413 (Direct) | View |
| 2021-02-28 Option Award | 2021-03-02 5:57 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | Chiniara Ellen EVP & Chief Legal Officer | 19,321 | $0 | 62,381 (Direct) | View |
| 2021-02-28 Option Award | 2021-03-02 5:55 pm | N/A N/A | ALEXION PHARMACEUTICALS INC. | ALXN | Goff Brian EVP & Chief Commercial Officer | 24,473 | $0 | 91,774 (Direct) | View |